|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Llovet JM, Zucman-Rossi J, Pikarsky E,
Sangro B, Schwartz M, Sherman M and Gores G: Hepatocellular
carcinoma. Nat Revi Dis Primers. 2(16018)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang H, Lu Z and Zhao X: Tumorigenesis,
diagnosis, and therapeutic potential of exosomes in liver cancer. J
Hematol Oncol. 12(133)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Llovet JM, Montal R, Sia D and Finn RS:
Molecular therapies and precision medicine for hepatocellular
carcinoma. Nat Rev Clin Oncol. 15:599–616. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ma S, Sun J, Guo Y, Zhang P, Liu Y, Zheng
D and Shi J: Combination of AAV-TRAIL with miR-221-Zip therapeutic
strategy overcomes the resistance to TRAIL induced apoptosis in
liver cancer. Theranostics. 7:3228–3242. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen Y, He Y and Zhou H: The potential
role of lncRNAs in diabetes and diabetic microvascular
complications. Endocr J. 67:659–668. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu
J, Miao N, Shen J and Peng T: lncRNA DANCR promotes tumor
progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhu L and Xu PC: Downregulated LncRNA-ANCR
promotes osteoblast differentiation by targeting EZH2 and
regulating Runx2 expression. Biochem Biophys Res Commun.
432:612–617. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li C, Chen J, Zhang K, Feng B, Wang R and
Chen L: Progress and prospects of long noncoding RNAs (lncRNAs) in
hepatocellular carcinoma. Cell Physiol Biochem. 36:423–434.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16(136)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long
noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor
prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Clark ME, Kelner GS, Turbeville LA, Boyer
A, Arden KC and Maki RA: ADAMTS9, a novel member of the
ADAM-TS/metallospondin gene family. Genomics. 67:343–350.
2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang X, Luo G, Zhang K, Cao J, Huang C,
Jiang T, Liu B, Su L and Qiu Z: Hypoxic tumor-derived exosomal
miR-301a mediates M2 macrophage polarization via PI3Kγ to promote
pancreatic cancer metastasis. Cancer Res. 78:4586–4598.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu C, Yang Z, Deng Z, Zhou Y, Gong Q,
Zhao R and Chen T: Upregulated lncRNA ADAMTS9-AS2 suppresses
progression of lung cancer through inhibition of miR-223-3p and
promotion of TGFBR3. IUBMB Life. 70:536–546. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Xie S, Yu X, Li Y, Ma H, Fan S, Chen W,
Pan G, Wang W, Zhang H, Li J and Lin Z: Upregulation of lncRNA
ADAMTS9-AS2 promotes salivary adenoid cystic carcinoma metastasis
via PI3K/Akt and MEK/Erk signaling. Mol Ther. 26:2766–2778.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jin Z, Yao J, Xie N, Cai L, Qi S, Zhang Z
and Li B: Melittin constrains the expression of identified key
genes associated with bladder cancer. J Immunol Res.
2018(5038172)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu X, Zhang W, Guo H, Yue J and Zhuo S:
miR-98 functions as a tumor suppressor in salivary adenoid cystic
carcinomas. Onco Targets Ther. 9:1777–1786. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shu Ting WFS: PI3K/Akt/mTOR signaling
pathway and its role in autophagy and tumor. Chin J Biochem Mol
Biol. 32:1192–1196. 2016.
|
|
24
|
Huang JL, Cao SW, Ou QS, Yang B, Zheng SH,
Tang J, Chen J, Hu YW, Zheng L and Wang Q: The long non-coding RNA
PTTG3P promotes cell growth and metastasis via up-regulating PTTG1
and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol
Cancer. 17(93)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Qiu L, Tang Q, Li G and Chen K: Long
non-coding RNAs as biomarkers and therapeutic targets: Recent
insights into hepatocellular carcinoma. Life Sci. 191:273–282.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hu W, Feng H, Xu X, Huang X, Huang X, Chen
W, Hao L and Xia W: Long noncoding RNA FOXD2-AS1 aggravates
hepatocellular carcinoma tumorigenesis by regulating the
miR-206/MAP3K1 axis. Cancer Med. 9:5620–5631. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu
Y and Zhu W: A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated
by DNMT1 and inhibits migration of glioma cells. Tumour Biol.
35:7935–7944. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Du W, Wang S, Zhou Q, Li X, Chu J, Chang
Z, Tao Q, Ng EK, Fang J, Sung JJ and Yu J: ADAMTS9 is a functional
tumor suppressor through inhibiting AKT/mTOR pathway and associated
with poor survival in gastric cancer. Oncogene. 32:3319–3328.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li TT, Zhu D, Mou T, Guo Z, Pu JL, Chen
QS, Wei XF and Wu ZJ: IL-37 induces autophagy in hepatocellular
carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Mol
Immunol. 87:132–140. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang P, Guo QS, Wang ZW and Qian HX: HBx
induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway. Mol
Cell Biochem. 372:161–168. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang S, Zhu M, Wang Q, Hou Y, Li L, Weng
H, Zhao Y, Chen D, Ding H, Guo J and Li M: Alpha-fetoprotein
inhibits autophagy to promote malignant behaviour in hepatocellular
carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death
Dis. 9(1027)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang SS, Chen YH, Chen N, Wang LJ, Chen
DX, Weng HL, Dooley S and Ding HG: Hydrogen sulfide promotes
autophagy of hepatocellular carcinoma cells through the
PI3K/Akt/mTOR signaling pathway. Cell Death Dis.
8(e2688)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Singh R and Cuervo AM: Autophagy in the
cellular energetic balance. Cell Metab. 13:495–504. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hua F, Shang S and Hu ZW: Seeking new
anti-cancer agents from autophagy-regulating natural products. J
Asian Nat Prod Res. 19:305–313. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li YY, Feun LG, Thongkum A, Tu CH, Chen
SM, Wangpaichitr M, Wu C, Kuo MT and Savaraj N: Autophagic
mechanism in anti-cancer immunity: Its pros and cons for cancer
therapy. Int J Mol Sci. 18(1297)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lamark T, Svenning S and Johansen T:
Regulation of selective autophagy: The p62/SQSTM1 paradigm. Essays
Biochem. 61:609–624. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
He R, Peng J, Yuan P, Xu F and Wei W:
Divergent roles of BECN1 in LC3 lipidation and autophagosomal
function. Autophagy. 11:740–747. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014(150845)2014.PubMed/NCBI View Article : Google Scholar
|
